Cell and Gene Therapy Business Outlook

    Published: January 1, 2022 | Price: $4,995 – $30,000

    How Do You Plan to Keep Up With Developments in The Business of Cell and Gene Therapy in 2022? Consider Cell and Gene Therapy Business Outlook Each week brings news in Cell and Gene Therapy, from advances in clinical trials to product launches, from tools development to mergers and acquisitions.  It can be a daunting task to keep up.  Yet these developments are too fast-moving and significant for healthcare companies of any type to ignore.  Now from Science and Medicine...
    In Vitro Diagnostics Business Outlook

    Published: January 1, 2022 | Price: $4,995 – $30,000

    From Kalorama Information and Science and Medicine Group (publishers of Instrument Business Outlook) comes a new publication focusing on the business of clinical testing. In Vitro Diagnostics Business Outlook offers the following: Market Sizing and Forecasting of IVD Market Segments in Every Issue Clinical Chemistry, Infectious Disease Testing, Oncology, Hematology, Blood Banking, Coagulation, Point of Care–Updates on the Important Test Categories You Need to Know About Industry Watch – Developments with COVID-19 and Other Testing   M&A, Distribution, Partnerships Tracked...